Global Swollen Knee Market

Swollen Knee Comprehensive Study by Type (Acute Knee Swelling, Chronic Knee Swelling), Treatment (Medications, Surgical Procedures (Arthrocentesis, Arthroscopy and Joint replacement)), End-user (Hospitals, Clinics, Ambulatory Surgical Centres), Diagnosis (X-ray, Ultrasound, MRI, Joint Aspiration) Players and Region - Global Market Outlook to 2026

Swollen Knee Market by XX Submarkets | Forecast Years 2022-2027  

Access Sample Report Make An Enquiry Before Purchase
  • Summary
  • Market Segments
  • Table of Content
  • List of Table & Figures
  • Players Profiled
What is Swollen Knee Market?

A swollen knee occurs when excess fluid accumulates in or around the patient's knee joint that may limit knee flexibility and function. It may be the result of overuse injuries, trauma, or an underlying disease or condition. Knee swelling can be acute or chronic, acute swelling may result from an injury and disappear within a day and chronic swelling can last much longer and signal an underlying medical condition.

The market study is being classified by Type (Acute Knee Swelling and Chronic Knee Swelling) and major geographies with country level break-up.

Smith & Nephew Plc. (United Kingdom), DePuy Companies Inc. (United States), Wright Medical Group Inc. (United States), Stryker Corporation (United States), Zimmer Biomet (United States), B. Braun Melsungen AG (Germany), Pfizer Pharmaceuticals Inc. (United States), Merck & Co., Inc. (United States), Fresenius Kabi (United States), AngioDynamics, Inc. (United States), Teleflex (United States) and Smiths Medical, Inc. (United States) are some of the key players profiled in the study. Additionally, the Players which are also part of the research are C. R. Bard, Inc. (United States) and Exactech, Inc. (United States).

The companies are exploring the market by adopting expansions, investments, new service launches and collaborations as their preferred strategies. The players are exploring new geographies through expansions and acquisitions across the globe to gain a competitive advantage through combined collaborations. Research Analyst at AMA predicts that United States Players will contribute to the maximum growth of Global Swollen Knee market throughout the predicted period.

Segment Analysis
Analyst at AMA have segmented the market study of Global Swollen Knee market by Type, Application and Region.

On the basis of geography, the market of Swollen Knee has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico). Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth.

Market Drivers
  • Rise in the Prevalence of Chronic Knee Diseases
  • Increased Number of Road Accidents Worldwide

Market Trend
  • Technological Advancements in the Medical Science
  • Increased Number of Surgeries Performed

Restraints
  • High Cost of Treatment

Opportunities
  • Growth in the Geriatric Population
  • Growing Healthcare Industry Worldwide

Challenges
  • Increasing Competition in the Market





Key Target Audience
Swollen Knee Treatment Providers, Emerging Companies, Research Professionals and End-users

Report Objectives / Segmentation Covered

By Type
  • Acute Knee Swelling
  • Chronic Knee Swelling
By Treatment
  • Medications
  • Surgical Procedures (Arthrocentesis, Arthroscopy and Joint replacement)

By End-user
  • Hospitals
  • Clinics
  • Ambulatory Surgical Centres

By Diagnosis
  • X-ray
  • Ultrasound
  • MRI
  • Joint Aspiration

By Regions
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Taiwan
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • Italy
    • United Kingdom
    • Netherlands
    • Rest of Europe
  • MEA
    • Middle East
    • Africa
  • North America
    • United States
    • Canada
    • Mexico
  • 1. Market Overview
    • 1.1. Introduction
    • 1.2. Scope/Objective of the Study
      • 1.2.1. Research Objective
  • 2. Executive Summary
    • 2.1. Introduction
  • 3. Market Dynamics
    • 3.1. Introduction
    • 3.2. Market Drivers
      • 3.2.1. Rise in the Prevalence of Chronic Knee Diseases
      • 3.2.2. Increased Number of Road Accidents Worldwide
    • 3.3. Market Challenges
      • 3.3.1. Increasing Competition in the Market
    • 3.4. Market Trends
      • 3.4.1. Technological Advancements in the Medical Science
      • 3.4.2. Increased Number of Surgeries Performed
  • 4. Market Factor Analysis
    • 4.1. Porters Five Forces
    • 4.2. Supply/Value Chain
    • 4.3. PESTEL analysis
    • 4.4. Market Entropy
    • 4.5. Patent/Trademark Analysis
  • 5. Global Swollen Knee, by Type, Treatment, End-user, Diagnosis and Region (value) (2015-2020)
    • 5.1. Introduction
    • 5.2. Global Swollen Knee (Value)
      • 5.2.1. Global Swollen Knee by: Type (Value)
        • 5.2.1.1. Acute Knee Swelling
        • 5.2.1.2. Chronic Knee Swelling
      • 5.2.2. Global Swollen Knee by: Treatment (Value)
        • 5.2.2.1. Medications
        • 5.2.2.2. Surgical Procedures (Arthrocentesis, Arthroscopy and Joint replacement)
      • 5.2.3. Global Swollen Knee by: End-user (Value)
        • 5.2.3.1. Hospitals
        • 5.2.3.2. Clinics
        • 5.2.3.3. Ambulatory Surgical Centres
      • 5.2.4. Global Swollen Knee by: Diagnosis (Value)
        • 5.2.4.1. X-ray
        • 5.2.4.2. Ultrasound
        • 5.2.4.3. MRI
        • 5.2.4.4. Joint Aspiration
      • 5.2.5. Global Swollen Knee Region
        • 5.2.5.1. South America
          • 5.2.5.1.1. Brazil
          • 5.2.5.1.2. Argentina
          • 5.2.5.1.3. Rest of South America
        • 5.2.5.2. Asia Pacific
          • 5.2.5.2.1. China
          • 5.2.5.2.2. Japan
          • 5.2.5.2.3. India
          • 5.2.5.2.4. South Korea
          • 5.2.5.2.5. Taiwan
          • 5.2.5.2.6. Australia
          • 5.2.5.2.7. Rest of Asia-Pacific
        • 5.2.5.3. Europe
          • 5.2.5.3.1. Germany
          • 5.2.5.3.2. France
          • 5.2.5.3.3. Italy
          • 5.2.5.3.4. United Kingdom
          • 5.2.5.3.5. Netherlands
          • 5.2.5.3.6. Rest of Europe
        • 5.2.5.4. MEA
          • 5.2.5.4.1. Middle East
          • 5.2.5.4.2. Africa
        • 5.2.5.5. North America
          • 5.2.5.5.1. United States
          • 5.2.5.5.2. Canada
          • 5.2.5.5.3. Mexico
  • 6. Swollen Knee: Manufacturers/Players Analysis
    • 6.1. Competitive Landscape
      • 6.1.1. Market Share Analysis
        • 6.1.1.1. Top 3
        • 6.1.1.2. Top 5
    • 6.2. Peer Group Analysis (2020)
    • 6.3. BCG Matrix
    • 6.4. Company Profile
      • 6.4.1. Smith & Nephew Plc. (United Kingdom)
        • 6.4.1.1. Business Overview
        • 6.4.1.2. Products/Services Offerings
        • 6.4.1.3. Financial Analysis
        • 6.4.1.4. SWOT Analysis
      • 6.4.2. DePuy Companies Inc. (United States)
        • 6.4.2.1. Business Overview
        • 6.4.2.2. Products/Services Offerings
        • 6.4.2.3. Financial Analysis
        • 6.4.2.4. SWOT Analysis
      • 6.4.3. Wright Medical Group Inc. (United States)
        • 6.4.3.1. Business Overview
        • 6.4.3.2. Products/Services Offerings
        • 6.4.3.3. Financial Analysis
        • 6.4.3.4. SWOT Analysis
      • 6.4.4. Stryker Corporation (United States)
        • 6.4.4.1. Business Overview
        • 6.4.4.2. Products/Services Offerings
        • 6.4.4.3. Financial Analysis
        • 6.4.4.4. SWOT Analysis
      • 6.4.5. Zimmer Biomet (United States)
        • 6.4.5.1. Business Overview
        • 6.4.5.2. Products/Services Offerings
        • 6.4.5.3. Financial Analysis
        • 6.4.5.4. SWOT Analysis
      • 6.4.6. B. Braun Melsungen AG (Germany)
        • 6.4.6.1. Business Overview
        • 6.4.6.2. Products/Services Offerings
        • 6.4.6.3. Financial Analysis
        • 6.4.6.4. SWOT Analysis
      • 6.4.7. Pfizer Pharmaceuticals Inc. (United States)
        • 6.4.7.1. Business Overview
        • 6.4.7.2. Products/Services Offerings
        • 6.4.7.3. Financial Analysis
        • 6.4.7.4. SWOT Analysis
      • 6.4.8. Merck & Co., Inc. (United States)
        • 6.4.8.1. Business Overview
        • 6.4.8.2. Products/Services Offerings
        • 6.4.8.3. Financial Analysis
        • 6.4.8.4. SWOT Analysis
      • 6.4.9. Fresenius Kabi (United States)
        • 6.4.9.1. Business Overview
        • 6.4.9.2. Products/Services Offerings
        • 6.4.9.3. Financial Analysis
        • 6.4.9.4. SWOT Analysis
      • 6.4.10. AngioDynamics, Inc. (United States)
        • 6.4.10.1. Business Overview
        • 6.4.10.2. Products/Services Offerings
        • 6.4.10.3. Financial Analysis
        • 6.4.10.4. SWOT Analysis
      • 6.4.11. Teleflex (United States)
        • 6.4.11.1. Business Overview
        • 6.4.11.2. Products/Services Offerings
        • 6.4.11.3. Financial Analysis
        • 6.4.11.4. SWOT Analysis
      • 6.4.12. Smiths Medical, Inc. (United States)
        • 6.4.12.1. Business Overview
        • 6.4.12.2. Products/Services Offerings
        • 6.4.12.3. Financial Analysis
        • 6.4.12.4. SWOT Analysis
  • 7. Global Swollen Knee Sale, by Type, Treatment, End-user, Diagnosis and Region (value) (2021-2026)
    • 7.1. Introduction
    • 7.2. Global Swollen Knee (Value)
      • 7.2.1. Global Swollen Knee by: Type (Value)
        • 7.2.1.1. Acute Knee Swelling
        • 7.2.1.2. Chronic Knee Swelling
      • 7.2.2. Global Swollen Knee by: Treatment (Value)
        • 7.2.2.1. Medications
        • 7.2.2.2. Surgical Procedures (Arthrocentesis, Arthroscopy and Joint replacement)
      • 7.2.3. Global Swollen Knee by: End-user (Value)
        • 7.2.3.1. Hospitals
        • 7.2.3.2. Clinics
        • 7.2.3.3. Ambulatory Surgical Centres
      • 7.2.4. Global Swollen Knee by: Diagnosis (Value)
        • 7.2.4.1. X-ray
        • 7.2.4.2. Ultrasound
        • 7.2.4.3. MRI
        • 7.2.4.4. Joint Aspiration
      • 7.2.5. Global Swollen Knee Region
        • 7.2.5.1. South America
          • 7.2.5.1.1. Brazil
          • 7.2.5.1.2. Argentina
          • 7.2.5.1.3. Rest of South America
        • 7.2.5.2. Asia Pacific
          • 7.2.5.2.1. China
          • 7.2.5.2.2. Japan
          • 7.2.5.2.3. India
          • 7.2.5.2.4. South Korea
          • 7.2.5.2.5. Taiwan
          • 7.2.5.2.6. Australia
          • 7.2.5.2.7. Rest of Asia-Pacific
        • 7.2.5.3. Europe
          • 7.2.5.3.1. Germany
          • 7.2.5.3.2. France
          • 7.2.5.3.3. Italy
          • 7.2.5.3.4. United Kingdom
          • 7.2.5.3.5. Netherlands
          • 7.2.5.3.6. Rest of Europe
        • 7.2.5.4. MEA
          • 7.2.5.4.1. Middle East
          • 7.2.5.4.2. Africa
        • 7.2.5.5. North America
          • 7.2.5.5.1. United States
          • 7.2.5.5.2. Canada
          • 7.2.5.5.3. Mexico
  • 8. Appendix
    • 8.1. Acronyms
  • 9. Methodology and Data Source
    • 9.1. Methodology/Research Approach
      • 9.1.1. Research Programs/Design
      • 9.1.2. Market Size Estimation
      • 9.1.3. Market Breakdown and Data Triangulation
    • 9.2. Data Source
      • 9.2.1. Secondary Sources
      • 9.2.2. Primary Sources
    • 9.3. Disclaimer
List of Tables
  • Table 1. Swollen Knee: by Type(USD Million)
  • Table 2. Swollen Knee Acute Knee Swelling , by Region USD Million (2015-2020)
  • Table 3. Swollen Knee Chronic Knee Swelling , by Region USD Million (2015-2020)
  • Table 4. Swollen Knee: by Treatment(USD Million)
  • Table 5. Swollen Knee Medications , by Region USD Million (2015-2020)
  • Table 6. Swollen Knee Surgical Procedures (Arthrocentesis, Arthroscopy and Joint replacement) , by Region USD Million (2015-2020)
  • Table 7. Swollen Knee: by End-user(USD Million)
  • Table 8. Swollen Knee Hospitals , by Region USD Million (2015-2020)
  • Table 9. Swollen Knee Clinics , by Region USD Million (2015-2020)
  • Table 10. Swollen Knee Ambulatory Surgical Centres , by Region USD Million (2015-2020)
  • Table 11. Swollen Knee: by Diagnosis(USD Million)
  • Table 12. Swollen Knee X-ray , by Region USD Million (2015-2020)
  • Table 13. Swollen Knee Ultrasound , by Region USD Million (2015-2020)
  • Table 14. Swollen Knee MRI , by Region USD Million (2015-2020)
  • Table 15. Swollen Knee Joint Aspiration , by Region USD Million (2015-2020)
  • Table 16. South America Swollen Knee, by Country USD Million (2015-2020)
  • Table 17. South America Swollen Knee, by Type USD Million (2015-2020)
  • Table 18. South America Swollen Knee, by Treatment USD Million (2015-2020)
  • Table 19. South America Swollen Knee, by End-user USD Million (2015-2020)
  • Table 20. South America Swollen Knee, by Diagnosis USD Million (2015-2020)
  • Table 21. Brazil Swollen Knee, by Type USD Million (2015-2020)
  • Table 22. Brazil Swollen Knee, by Treatment USD Million (2015-2020)
  • Table 23. Brazil Swollen Knee, by End-user USD Million (2015-2020)
  • Table 24. Brazil Swollen Knee, by Diagnosis USD Million (2015-2020)
  • Table 25. Argentina Swollen Knee, by Type USD Million (2015-2020)
  • Table 26. Argentina Swollen Knee, by Treatment USD Million (2015-2020)
  • Table 27. Argentina Swollen Knee, by End-user USD Million (2015-2020)
  • Table 28. Argentina Swollen Knee, by Diagnosis USD Million (2015-2020)
  • Table 29. Rest of South America Swollen Knee, by Type USD Million (2015-2020)
  • Table 30. Rest of South America Swollen Knee, by Treatment USD Million (2015-2020)
  • Table 31. Rest of South America Swollen Knee, by End-user USD Million (2015-2020)
  • Table 32. Rest of South America Swollen Knee, by Diagnosis USD Million (2015-2020)
  • Table 33. Asia Pacific Swollen Knee, by Country USD Million (2015-2020)
  • Table 34. Asia Pacific Swollen Knee, by Type USD Million (2015-2020)
  • Table 35. Asia Pacific Swollen Knee, by Treatment USD Million (2015-2020)
  • Table 36. Asia Pacific Swollen Knee, by End-user USD Million (2015-2020)
  • Table 37. Asia Pacific Swollen Knee, by Diagnosis USD Million (2015-2020)
  • Table 38. China Swollen Knee, by Type USD Million (2015-2020)
  • Table 39. China Swollen Knee, by Treatment USD Million (2015-2020)
  • Table 40. China Swollen Knee, by End-user USD Million (2015-2020)
  • Table 41. China Swollen Knee, by Diagnosis USD Million (2015-2020)
  • Table 42. Japan Swollen Knee, by Type USD Million (2015-2020)
  • Table 43. Japan Swollen Knee, by Treatment USD Million (2015-2020)
  • Table 44. Japan Swollen Knee, by End-user USD Million (2015-2020)
  • Table 45. Japan Swollen Knee, by Diagnosis USD Million (2015-2020)
  • Table 46. India Swollen Knee, by Type USD Million (2015-2020)
  • Table 47. India Swollen Knee, by Treatment USD Million (2015-2020)
  • Table 48. India Swollen Knee, by End-user USD Million (2015-2020)
  • Table 49. India Swollen Knee, by Diagnosis USD Million (2015-2020)
  • Table 50. South Korea Swollen Knee, by Type USD Million (2015-2020)
  • Table 51. South Korea Swollen Knee, by Treatment USD Million (2015-2020)
  • Table 52. South Korea Swollen Knee, by End-user USD Million (2015-2020)
  • Table 53. South Korea Swollen Knee, by Diagnosis USD Million (2015-2020)
  • Table 54. Taiwan Swollen Knee, by Type USD Million (2015-2020)
  • Table 55. Taiwan Swollen Knee, by Treatment USD Million (2015-2020)
  • Table 56. Taiwan Swollen Knee, by End-user USD Million (2015-2020)
  • Table 57. Taiwan Swollen Knee, by Diagnosis USD Million (2015-2020)
  • Table 58. Australia Swollen Knee, by Type USD Million (2015-2020)
  • Table 59. Australia Swollen Knee, by Treatment USD Million (2015-2020)
  • Table 60. Australia Swollen Knee, by End-user USD Million (2015-2020)
  • Table 61. Australia Swollen Knee, by Diagnosis USD Million (2015-2020)
  • Table 62. Rest of Asia-Pacific Swollen Knee, by Type USD Million (2015-2020)
  • Table 63. Rest of Asia-Pacific Swollen Knee, by Treatment USD Million (2015-2020)
  • Table 64. Rest of Asia-Pacific Swollen Knee, by End-user USD Million (2015-2020)
  • Table 65. Rest of Asia-Pacific Swollen Knee, by Diagnosis USD Million (2015-2020)
  • Table 66. Europe Swollen Knee, by Country USD Million (2015-2020)
  • Table 67. Europe Swollen Knee, by Type USD Million (2015-2020)
  • Table 68. Europe Swollen Knee, by Treatment USD Million (2015-2020)
  • Table 69. Europe Swollen Knee, by End-user USD Million (2015-2020)
  • Table 70. Europe Swollen Knee, by Diagnosis USD Million (2015-2020)
  • Table 71. Germany Swollen Knee, by Type USD Million (2015-2020)
  • Table 72. Germany Swollen Knee, by Treatment USD Million (2015-2020)
  • Table 73. Germany Swollen Knee, by End-user USD Million (2015-2020)
  • Table 74. Germany Swollen Knee, by Diagnosis USD Million (2015-2020)
  • Table 75. France Swollen Knee, by Type USD Million (2015-2020)
  • Table 76. France Swollen Knee, by Treatment USD Million (2015-2020)
  • Table 77. France Swollen Knee, by End-user USD Million (2015-2020)
  • Table 78. France Swollen Knee, by Diagnosis USD Million (2015-2020)
  • Table 79. Italy Swollen Knee, by Type USD Million (2015-2020)
  • Table 80. Italy Swollen Knee, by Treatment USD Million (2015-2020)
  • Table 81. Italy Swollen Knee, by End-user USD Million (2015-2020)
  • Table 82. Italy Swollen Knee, by Diagnosis USD Million (2015-2020)
  • Table 83. United Kingdom Swollen Knee, by Type USD Million (2015-2020)
  • Table 84. United Kingdom Swollen Knee, by Treatment USD Million (2015-2020)
  • Table 85. United Kingdom Swollen Knee, by End-user USD Million (2015-2020)
  • Table 86. United Kingdom Swollen Knee, by Diagnosis USD Million (2015-2020)
  • Table 87. Netherlands Swollen Knee, by Type USD Million (2015-2020)
  • Table 88. Netherlands Swollen Knee, by Treatment USD Million (2015-2020)
  • Table 89. Netherlands Swollen Knee, by End-user USD Million (2015-2020)
  • Table 90. Netherlands Swollen Knee, by Diagnosis USD Million (2015-2020)
  • Table 91. Rest of Europe Swollen Knee, by Type USD Million (2015-2020)
  • Table 92. Rest of Europe Swollen Knee, by Treatment USD Million (2015-2020)
  • Table 93. Rest of Europe Swollen Knee, by End-user USD Million (2015-2020)
  • Table 94. Rest of Europe Swollen Knee, by Diagnosis USD Million (2015-2020)
  • Table 95. MEA Swollen Knee, by Country USD Million (2015-2020)
  • Table 96. MEA Swollen Knee, by Type USD Million (2015-2020)
  • Table 97. MEA Swollen Knee, by Treatment USD Million (2015-2020)
  • Table 98. MEA Swollen Knee, by End-user USD Million (2015-2020)
  • Table 99. MEA Swollen Knee, by Diagnosis USD Million (2015-2020)
  • Table 100. Middle East Swollen Knee, by Type USD Million (2015-2020)
  • Table 101. Middle East Swollen Knee, by Treatment USD Million (2015-2020)
  • Table 102. Middle East Swollen Knee, by End-user USD Million (2015-2020)
  • Table 103. Middle East Swollen Knee, by Diagnosis USD Million (2015-2020)
  • Table 104. Africa Swollen Knee, by Type USD Million (2015-2020)
  • Table 105. Africa Swollen Knee, by Treatment USD Million (2015-2020)
  • Table 106. Africa Swollen Knee, by End-user USD Million (2015-2020)
  • Table 107. Africa Swollen Knee, by Diagnosis USD Million (2015-2020)
  • Table 108. North America Swollen Knee, by Country USD Million (2015-2020)
  • Table 109. North America Swollen Knee, by Type USD Million (2015-2020)
  • Table 110. North America Swollen Knee, by Treatment USD Million (2015-2020)
  • Table 111. North America Swollen Knee, by End-user USD Million (2015-2020)
  • Table 112. North America Swollen Knee, by Diagnosis USD Million (2015-2020)
  • Table 113. United States Swollen Knee, by Type USD Million (2015-2020)
  • Table 114. United States Swollen Knee, by Treatment USD Million (2015-2020)
  • Table 115. United States Swollen Knee, by End-user USD Million (2015-2020)
  • Table 116. United States Swollen Knee, by Diagnosis USD Million (2015-2020)
  • Table 117. Canada Swollen Knee, by Type USD Million (2015-2020)
  • Table 118. Canada Swollen Knee, by Treatment USD Million (2015-2020)
  • Table 119. Canada Swollen Knee, by End-user USD Million (2015-2020)
  • Table 120. Canada Swollen Knee, by Diagnosis USD Million (2015-2020)
  • Table 121. Mexico Swollen Knee, by Type USD Million (2015-2020)
  • Table 122. Mexico Swollen Knee, by Treatment USD Million (2015-2020)
  • Table 123. Mexico Swollen Knee, by End-user USD Million (2015-2020)
  • Table 124. Mexico Swollen Knee, by Diagnosis USD Million (2015-2020)
  • Table 125. Company Basic Information, Sales Area and Its Competitors
  • Table 126. Company Basic Information, Sales Area and Its Competitors
  • Table 127. Company Basic Information, Sales Area and Its Competitors
  • Table 128. Company Basic Information, Sales Area and Its Competitors
  • Table 129. Company Basic Information, Sales Area and Its Competitors
  • Table 130. Company Basic Information, Sales Area and Its Competitors
  • Table 131. Company Basic Information, Sales Area and Its Competitors
  • Table 132. Company Basic Information, Sales Area and Its Competitors
  • Table 133. Company Basic Information, Sales Area and Its Competitors
  • Table 134. Company Basic Information, Sales Area and Its Competitors
  • Table 135. Company Basic Information, Sales Area and Its Competitors
  • Table 136. Company Basic Information, Sales Area and Its Competitors
  • Table 137. Swollen Knee: by Type(USD Million)
  • Table 138. Swollen Knee Acute Knee Swelling , by Region USD Million (2021-2026)
  • Table 139. Swollen Knee Chronic Knee Swelling , by Region USD Million (2021-2026)
  • Table 140. Swollen Knee: by Treatment(USD Million)
  • Table 141. Swollen Knee Medications , by Region USD Million (2021-2026)
  • Table 142. Swollen Knee Surgical Procedures (Arthrocentesis, Arthroscopy and Joint replacement) , by Region USD Million (2021-2026)
  • Table 143. Swollen Knee: by End-user(USD Million)
  • Table 144. Swollen Knee Hospitals , by Region USD Million (2021-2026)
  • Table 145. Swollen Knee Clinics , by Region USD Million (2021-2026)
  • Table 146. Swollen Knee Ambulatory Surgical Centres , by Region USD Million (2021-2026)
  • Table 147. Swollen Knee: by Diagnosis(USD Million)
  • Table 148. Swollen Knee X-ray , by Region USD Million (2021-2026)
  • Table 149. Swollen Knee Ultrasound , by Region USD Million (2021-2026)
  • Table 150. Swollen Knee MRI , by Region USD Million (2021-2026)
  • Table 151. Swollen Knee Joint Aspiration , by Region USD Million (2021-2026)
  • Table 152. South America Swollen Knee, by Country USD Million (2021-2026)
  • Table 153. South America Swollen Knee, by Type USD Million (2021-2026)
  • Table 154. South America Swollen Knee, by Treatment USD Million (2021-2026)
  • Table 155. South America Swollen Knee, by End-user USD Million (2021-2026)
  • Table 156. South America Swollen Knee, by Diagnosis USD Million (2021-2026)
  • Table 157. Brazil Swollen Knee, by Type USD Million (2021-2026)
  • Table 158. Brazil Swollen Knee, by Treatment USD Million (2021-2026)
  • Table 159. Brazil Swollen Knee, by End-user USD Million (2021-2026)
  • Table 160. Brazil Swollen Knee, by Diagnosis USD Million (2021-2026)
  • Table 161. Argentina Swollen Knee, by Type USD Million (2021-2026)
  • Table 162. Argentina Swollen Knee, by Treatment USD Million (2021-2026)
  • Table 163. Argentina Swollen Knee, by End-user USD Million (2021-2026)
  • Table 164. Argentina Swollen Knee, by Diagnosis USD Million (2021-2026)
  • Table 165. Rest of South America Swollen Knee, by Type USD Million (2021-2026)
  • Table 166. Rest of South America Swollen Knee, by Treatment USD Million (2021-2026)
  • Table 167. Rest of South America Swollen Knee, by End-user USD Million (2021-2026)
  • Table 168. Rest of South America Swollen Knee, by Diagnosis USD Million (2021-2026)
  • Table 169. Asia Pacific Swollen Knee, by Country USD Million (2021-2026)
  • Table 170. Asia Pacific Swollen Knee, by Type USD Million (2021-2026)
  • Table 171. Asia Pacific Swollen Knee, by Treatment USD Million (2021-2026)
  • Table 172. Asia Pacific Swollen Knee, by End-user USD Million (2021-2026)
  • Table 173. Asia Pacific Swollen Knee, by Diagnosis USD Million (2021-2026)
  • Table 174. China Swollen Knee, by Type USD Million (2021-2026)
  • Table 175. China Swollen Knee, by Treatment USD Million (2021-2026)
  • Table 176. China Swollen Knee, by End-user USD Million (2021-2026)
  • Table 177. China Swollen Knee, by Diagnosis USD Million (2021-2026)
  • Table 178. Japan Swollen Knee, by Type USD Million (2021-2026)
  • Table 179. Japan Swollen Knee, by Treatment USD Million (2021-2026)
  • Table 180. Japan Swollen Knee, by End-user USD Million (2021-2026)
  • Table 181. Japan Swollen Knee, by Diagnosis USD Million (2021-2026)
  • Table 182. India Swollen Knee, by Type USD Million (2021-2026)
  • Table 183. India Swollen Knee, by Treatment USD Million (2021-2026)
  • Table 184. India Swollen Knee, by End-user USD Million (2021-2026)
  • Table 185. India Swollen Knee, by Diagnosis USD Million (2021-2026)
  • Table 186. South Korea Swollen Knee, by Type USD Million (2021-2026)
  • Table 187. South Korea Swollen Knee, by Treatment USD Million (2021-2026)
  • Table 188. South Korea Swollen Knee, by End-user USD Million (2021-2026)
  • Table 189. South Korea Swollen Knee, by Diagnosis USD Million (2021-2026)
  • Table 190. Taiwan Swollen Knee, by Type USD Million (2021-2026)
  • Table 191. Taiwan Swollen Knee, by Treatment USD Million (2021-2026)
  • Table 192. Taiwan Swollen Knee, by End-user USD Million (2021-2026)
  • Table 193. Taiwan Swollen Knee, by Diagnosis USD Million (2021-2026)
  • Table 194. Australia Swollen Knee, by Type USD Million (2021-2026)
  • Table 195. Australia Swollen Knee, by Treatment USD Million (2021-2026)
  • Table 196. Australia Swollen Knee, by End-user USD Million (2021-2026)
  • Table 197. Australia Swollen Knee, by Diagnosis USD Million (2021-2026)
  • Table 198. Rest of Asia-Pacific Swollen Knee, by Type USD Million (2021-2026)
  • Table 199. Rest of Asia-Pacific Swollen Knee, by Treatment USD Million (2021-2026)
  • Table 200. Rest of Asia-Pacific Swollen Knee, by End-user USD Million (2021-2026)
  • Table 201. Rest of Asia-Pacific Swollen Knee, by Diagnosis USD Million (2021-2026)
  • Table 202. Europe Swollen Knee, by Country USD Million (2021-2026)
  • Table 203. Europe Swollen Knee, by Type USD Million (2021-2026)
  • Table 204. Europe Swollen Knee, by Treatment USD Million (2021-2026)
  • Table 205. Europe Swollen Knee, by End-user USD Million (2021-2026)
  • Table 206. Europe Swollen Knee, by Diagnosis USD Million (2021-2026)
  • Table 207. Germany Swollen Knee, by Type USD Million (2021-2026)
  • Table 208. Germany Swollen Knee, by Treatment USD Million (2021-2026)
  • Table 209. Germany Swollen Knee, by End-user USD Million (2021-2026)
  • Table 210. Germany Swollen Knee, by Diagnosis USD Million (2021-2026)
  • Table 211. France Swollen Knee, by Type USD Million (2021-2026)
  • Table 212. France Swollen Knee, by Treatment USD Million (2021-2026)
  • Table 213. France Swollen Knee, by End-user USD Million (2021-2026)
  • Table 214. France Swollen Knee, by Diagnosis USD Million (2021-2026)
  • Table 215. Italy Swollen Knee, by Type USD Million (2021-2026)
  • Table 216. Italy Swollen Knee, by Treatment USD Million (2021-2026)
  • Table 217. Italy Swollen Knee, by End-user USD Million (2021-2026)
  • Table 218. Italy Swollen Knee, by Diagnosis USD Million (2021-2026)
  • Table 219. United Kingdom Swollen Knee, by Type USD Million (2021-2026)
  • Table 220. United Kingdom Swollen Knee, by Treatment USD Million (2021-2026)
  • Table 221. United Kingdom Swollen Knee, by End-user USD Million (2021-2026)
  • Table 222. United Kingdom Swollen Knee, by Diagnosis USD Million (2021-2026)
  • Table 223. Netherlands Swollen Knee, by Type USD Million (2021-2026)
  • Table 224. Netherlands Swollen Knee, by Treatment USD Million (2021-2026)
  • Table 225. Netherlands Swollen Knee, by End-user USD Million (2021-2026)
  • Table 226. Netherlands Swollen Knee, by Diagnosis USD Million (2021-2026)
  • Table 227. Rest of Europe Swollen Knee, by Type USD Million (2021-2026)
  • Table 228. Rest of Europe Swollen Knee, by Treatment USD Million (2021-2026)
  • Table 229. Rest of Europe Swollen Knee, by End-user USD Million (2021-2026)
  • Table 230. Rest of Europe Swollen Knee, by Diagnosis USD Million (2021-2026)
  • Table 231. MEA Swollen Knee, by Country USD Million (2021-2026)
  • Table 232. MEA Swollen Knee, by Type USD Million (2021-2026)
  • Table 233. MEA Swollen Knee, by Treatment USD Million (2021-2026)
  • Table 234. MEA Swollen Knee, by End-user USD Million (2021-2026)
  • Table 235. MEA Swollen Knee, by Diagnosis USD Million (2021-2026)
  • Table 236. Middle East Swollen Knee, by Type USD Million (2021-2026)
  • Table 237. Middle East Swollen Knee, by Treatment USD Million (2021-2026)
  • Table 238. Middle East Swollen Knee, by End-user USD Million (2021-2026)
  • Table 239. Middle East Swollen Knee, by Diagnosis USD Million (2021-2026)
  • Table 240. Africa Swollen Knee, by Type USD Million (2021-2026)
  • Table 241. Africa Swollen Knee, by Treatment USD Million (2021-2026)
  • Table 242. Africa Swollen Knee, by End-user USD Million (2021-2026)
  • Table 243. Africa Swollen Knee, by Diagnosis USD Million (2021-2026)
  • Table 244. North America Swollen Knee, by Country USD Million (2021-2026)
  • Table 245. North America Swollen Knee, by Type USD Million (2021-2026)
  • Table 246. North America Swollen Knee, by Treatment USD Million (2021-2026)
  • Table 247. North America Swollen Knee, by End-user USD Million (2021-2026)
  • Table 248. North America Swollen Knee, by Diagnosis USD Million (2021-2026)
  • Table 249. United States Swollen Knee, by Type USD Million (2021-2026)
  • Table 250. United States Swollen Knee, by Treatment USD Million (2021-2026)
  • Table 251. United States Swollen Knee, by End-user USD Million (2021-2026)
  • Table 252. United States Swollen Knee, by Diagnosis USD Million (2021-2026)
  • Table 253. Canada Swollen Knee, by Type USD Million (2021-2026)
  • Table 254. Canada Swollen Knee, by Treatment USD Million (2021-2026)
  • Table 255. Canada Swollen Knee, by End-user USD Million (2021-2026)
  • Table 256. Canada Swollen Knee, by Diagnosis USD Million (2021-2026)
  • Table 257. Mexico Swollen Knee, by Type USD Million (2021-2026)
  • Table 258. Mexico Swollen Knee, by Treatment USD Million (2021-2026)
  • Table 259. Mexico Swollen Knee, by End-user USD Million (2021-2026)
  • Table 260. Mexico Swollen Knee, by Diagnosis USD Million (2021-2026)
  • Table 261. Research Programs/Design for This Report
  • Table 262. Key Data Information from Secondary Sources
  • Table 263. Key Data Information from Primary Sources
List of Figures
  • Figure 1. Porters Five Forces
  • Figure 2. Supply/Value Chain
  • Figure 3. PESTEL analysis
  • Figure 4. Global Swollen Knee: by Type USD Million (2015-2020)
  • Figure 5. Global Swollen Knee: by Treatment USD Million (2015-2020)
  • Figure 6. Global Swollen Knee: by End-user USD Million (2015-2020)
  • Figure 7. Global Swollen Knee: by Diagnosis USD Million (2015-2020)
  • Figure 8. South America Swollen Knee Share (%), by Country
  • Figure 9. Asia Pacific Swollen Knee Share (%), by Country
  • Figure 10. Europe Swollen Knee Share (%), by Country
  • Figure 11. MEA Swollen Knee Share (%), by Country
  • Figure 12. North America Swollen Knee Share (%), by Country
  • Figure 13. Global Swollen Knee share by Players 2020 (%)
  • Figure 14. Global Swollen Knee share by Players (Top 3) 2020(%)
  • Figure 15. Global Swollen Knee share by Players (Top 5) 2020(%)
  • Figure 16. BCG Matrix for key Companies
  • Figure 17. Smith & Nephew Plc. (United Kingdom) Revenue, Net Income and Gross profit
  • Figure 18. Smith & Nephew Plc. (United Kingdom) Revenue: by Geography 2020
  • Figure 19. DePuy Companies Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 20. DePuy Companies Inc. (United States) Revenue: by Geography 2020
  • Figure 21. Wright Medical Group Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 22. Wright Medical Group Inc. (United States) Revenue: by Geography 2020
  • Figure 23. Stryker Corporation (United States) Revenue, Net Income and Gross profit
  • Figure 24. Stryker Corporation (United States) Revenue: by Geography 2020
  • Figure 25. Zimmer Biomet (United States) Revenue, Net Income and Gross profit
  • Figure 26. Zimmer Biomet (United States) Revenue: by Geography 2020
  • Figure 27. B. Braun Melsungen AG (Germany) Revenue, Net Income and Gross profit
  • Figure 28. B. Braun Melsungen AG (Germany) Revenue: by Geography 2020
  • Figure 29. Pfizer Pharmaceuticals Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 30. Pfizer Pharmaceuticals Inc. (United States) Revenue: by Geography 2020
  • Figure 31. Merck & Co., Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 32. Merck & Co., Inc. (United States) Revenue: by Geography 2020
  • Figure 33. Fresenius Kabi (United States) Revenue, Net Income and Gross profit
  • Figure 34. Fresenius Kabi (United States) Revenue: by Geography 2020
  • Figure 35. AngioDynamics, Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 36. AngioDynamics, Inc. (United States) Revenue: by Geography 2020
  • Figure 37. Teleflex (United States) Revenue, Net Income and Gross profit
  • Figure 38. Teleflex (United States) Revenue: by Geography 2020
  • Figure 39. Smiths Medical, Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 40. Smiths Medical, Inc. (United States) Revenue: by Geography 2020
  • Figure 41. Global Swollen Knee: by Type USD Million (2021-2026)
  • Figure 42. Global Swollen Knee: by Treatment USD Million (2021-2026)
  • Figure 43. Global Swollen Knee: by End-user USD Million (2021-2026)
  • Figure 44. Global Swollen Knee: by Diagnosis USD Million (2021-2026)
  • Figure 45. South America Swollen Knee Share (%), by Country
  • Figure 46. Asia Pacific Swollen Knee Share (%), by Country
  • Figure 47. Europe Swollen Knee Share (%), by Country
  • Figure 48. MEA Swollen Knee Share (%), by Country
  • Figure 49. North America Swollen Knee Share (%), by Country
List of companies from research coverage that are profiled in the study
  • Smith & Nephew Plc. (United Kingdom)
  • DePuy Companies Inc. (United States)
  • Wright Medical Group Inc. (United States)
  • Stryker Corporation (United States)
  • Zimmer Biomet (United States)
  • B. Braun Melsungen AG (Germany)
  • Pfizer Pharmaceuticals Inc. (United States)
  • Merck & Co., Inc. (United States)
  • Fresenius Kabi (United States)
  • AngioDynamics, Inc. (United States)
  • Teleflex (United States)
  • Smiths Medical, Inc. (United States)
Additional players considered in the study are as follows:
C. R. Bard, Inc. (United States) , Exactech, Inc. (United States)
Select User Access Type

Key Highlights of Report


Mar 2021 236 Pages 53 Tables Base Year: 2021 Coverage: 15+ Companies; 18 Countries

Request Sample Pages

Budget constraints? Get in touch with us for special pricing


Check Discount Now
Global Swollen Knee Market Quantitative research analysis
Global Swollen Knee Market Qualitative Industry Analysis
DOWNLOAD SAMPLE PDF

Talk to Our Experts

Want to Customize Study?


"We employ Market statistics, Industry benchmarking, Patent analysis, and Technological Insights to derive requirements and provide customize scope of work."

Make an Enquiry Now

Frequently Asked Questions (FAQ):

"Rise in the Prevalence of Chronic Knee Diseases " is seen as one of major growth factors of Swollen Knee Market in years to come.
The Study can be customized subject to feasibility and data availability. Please connect with our sales representative for further information.

Know More About Global Swollen Knee Market Report?

Have a Query? Click Here

Other Related Reports

Diabetic Macular Edema Treatment Comprehensive Study by Type (Laser Photocoagulation Therapy, Pharmacological Therapy, Bevacizumab, Ranibizumab, Triamcinolone), Indication (Diffuse Diabetic Macular E...
$ 3750
Propionic Acidemia Comprehensive Study by Type (Neonatal-Onset PA, Late-Onset PA), Application (Hospitals & Clinics, Medicinal & Pharmaceutical Stores), Treatment Type (Carnitine Supplementation, Flu...
$ 3450
Ataxia-Telangiectasia Comprehensive Study by Distribution Channel (Hospital Pharmacies, Online Pharmacies), Diagnosis Type (IgA and Serum Alpha-1 Fetoprotein Levels, Genetic Testing), Treatment Type ...
$ 3350
Aplastic Anemia Treatment Comprehensive Study by Application (Adults, Kids), Disease Type (Acquired Aplastic Anemia, Inherited Bone Marrow Failure Syndromes (Inherited Aplastic Anemia)), Route of Adm...
$ 3750
Alexandrite Laser Treatment Comprehensive Study by Application (Aesthetic, Dermatology, Dentistry, Urology, Others), Indication (Vascular lesions, Pigmented lesions, Hair removal, Tattoo removal), En...
$ 3350
Fatty Acid Oxidation Disorder Comprehensive Study by Supplement Type (L-carnitine, L-carnitine, Medium Chain Triglyceride Oil), Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online St...
$ 3750